Followers | 13 |
Posts | 855 |
Boards Moderated | 0 |
Alias Born | 03/22/2022 |
![](https://investorshub.advfn.com/uicon/821434.png?cb=1650116392)
Thursday, March 30, 2023 1:56:48 PM
Way Overbought
Recent PYXS News
- Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 06/28/2024 08:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/12/2024 08:17:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/10/2024 11:56:02 AM
- Pyxis Oncology Expands Board of Directors with Appointment of Michael A. Metzger • GlobeNewswire Inc. • 06/10/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 09:00:32 PM
- Pyxis Oncology to Participate in a Fireside Chat at the Jefferies Global Healthcare Conference • GlobeNewswire Inc. • 05/30/2024 11:30:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2024 12:00:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 11:55:35 AM
- Pyxis Oncology Provides Corporate Update and Reports Financial Results for First Quarter 2024 • GlobeNewswire Inc. • 05/14/2024 11:30:00 AM
- Pyxis Oncology to Present at the RBC Capital Markets Global Healthcare Conference • GlobeNewswire Inc. • 05/09/2024 11:30:00 AM
- Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 03/28/2024 08:30:00 PM
- Pyxis Oncology Obtains $8 Million Payment for the Sale of Royalty Rights • GlobeNewswire Inc. • 03/27/2024 11:30:00 AM
- Pyxis Oncology Provides Corporate Update and Reports Financial Results for Fourth Quarter and Full Year 2023 • GlobeNewswire Inc. • 03/21/2024 11:30:00 AM
- Pyxis Oncology Expands Board of Directors with Appointment of Santhosh Palani, Ph.D., CFA • GlobeNewswire Inc. • 03/13/2024 12:00:00 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 03/08/2024 09:03:18 PM
- Pyxis Oncology to Present at Leerink Global Biopharma Conference 2024 • GlobeNewswire Inc. • 03/07/2024 09:30:00 PM
- Pyxis Oncology to Present New PYX-201, PYX-106 and PYX-102 Preclinical Data at AACR Annual Meeting • GlobeNewswire Inc. • 03/05/2024 09:45:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/28/2024 12:02:43 PM
- Pyxis Oncology Announces $50 Million Private Placement • GlobeNewswire Inc. • 02/27/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/29/2023 09:33:36 PM
- Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 12/29/2023 09:30:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 12/06/2023 09:50:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/30/2023 09:15:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/28/2023 12:22:15 PM
- Pyxis Oncology Announces Appointment of Ken Kobayashi, M.D., F.A.C.P as Chief Medical Officer • GlobeNewswire Inc. • 11/28/2023 12:00:00 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM